>> Technical intelligence and scientific intelligence for life sciences
LexisNexis®Analytics (LNA) is a longstanding specialist in scientific intelligence and technical intelligence, working with major pharma labs for more than 10 years. Our analysts have become experts in monitoring and editing customised analytical reports.
Accurate, up to date scientific intelligence and technical intelligence is essential for global pharmaceutical companies, who operate in a highly competitive market and must deal with a variety of stakeholders — not just health practioners. Today, company image relies on journalists, patients’ opinions, associations, NGOs, sometimes activists, trade unions, private health insurance and public health offices. Knowing the opinion of these stakeholders is the first step in driving the laboratory’s image.
> The web is the best media for the public to express what they think about laboratories and health issues. Manual tracking of the subjects that make up the laboratory's image – i.e. ethical and social practices, board effectiveness, R&D pipeline quality, transparency of relationships with governmental authorities, involvement in patients associations, or a product’s side-effects — would be partial and highly time-consuming. A laboratory also needs to know how it is perceived relative to its competitors.
> Fed with different types of information sources (major newspapers, stakeholders’ websites, scientific publications, social media), the LNA Monitor service allows a Communication Director to quickly and simply track the company's reputation. Combined with Reports and Executive Summaries, our technical intelligence and scientific intelligence solutions enable quick access to major critical or positive points (in various languages) identified during the monitoring period. Alerts provided via the service enhance an organisation's ability to react in the event of an emergency. Monitor saves time, money and helps to ensure your firm invests in the right issues.
> LNA's Dashboard tool allows you to track and benchmark visibility of the major pharmaceutical players (laboratories, CEOs, products) in their main markets, and to detect trends and identify the subject matters being associated with each laboratory. The effectiveness of communication actions can thus be assessed.